Search

The paper discusses different conceptualisations of the term globalisation of research. From this discussion five dimensions of globalisation of research are identified. Using three different type of data, the paper goes on to examine the extent, motivations and mechanism for the globalisation of research along these five dimensions among leading European and US pharmaceutical multinational companies (MNCs). The evidence for the period 1975–1998 shows that the general process of international expansion of research activities varied significantly between leading US and European MNCs. It is also clear that the development of the process of globalisation has proceeded unevenly along the five dimensions studied. The data also show the increasing concentration of both US and European research investment in the USA. [ABSTRACT FROM AUTHOR]

Most R&D resources in China were allocated to public research institutes/universities until the economic transition of the mid 1990s. To maximize the return from these resources, it is important to have a healthy collaboration between industry and research institutes/universities on industrial innovation. This paper examines that relationship and discusses some empirical evidence on its efficiency with particular reference to industry in Beijing. Following a survey of 950 industrial enterprises, the influences of the collaboration relationship on industrial innovation were analyzed. The main findings indicate that the technology novelty of industrial innovation is positively related to that relationship, i.e. the more the collaboration, the higher the technology novelty of the innovation. However, the collaboration relationship is less efficient in terms of economic performance indicators such as innovation sales and profit ratios, to measure innovation. Moreover, the collaboration relationship is still far from efficient in stimulating industrial innovation in China. The major barriers to successful collaboration have also been addressed in this paper with the aim of devising policies and suggesting possible improvements to collaboration efficiency. [ABSTRACT FROM AUTHOR]

Strategy has become an increasingly important theme within the management of innovation. This is reflected in the increasing amount of attention given to topics such as technology strategy within the innovation literature. However research into technology strategy has tended to focus on technology acquisition rather than technology exploitation. This paper focuses on one often neglected way in which companies can exploit the technological resources at their disposal, namely through the use of a derivative strategy where new technology is combined with old products or parts of old products in order to develop new products. The paper explores this type of strategy by means of a case study from the commercial jet engine sector of the aerospace industry. The case study provides an opportunity not only to explore the nature of derivative strategies in detail it also highlights the benefits, both direct and indirect, to be gained from this type of strategy as a means of exploiting an organisation's technological resources. The paper shows how a derivative strategy can contribute to the broader strategic goals of companies in technology based industries through strategies designed to ensure the most effective utilisation of the technology base. [ABSTRACT FROM AUTHOR]

Firms differ widely in their technological capabilities. Innovation policies are likely to be more or less successful depending upon the level of such abilities of those firms to which a policy is aimed. Without data on the proficiencies, strengths and weaknesses of firms within the target group(s), the construction and application of innovation or industrial policies are likely to miss salient factors in the ability of firms to benefit from the support that is intended. An in-depth knowledge of firms’ capabilities can allow policy-makers to target support according to the specific needs of firms. This paper describes the Technology capability audit tool (or CAT) that was designed to assist policy-makers in differentiating between firms and in understanding their level of ‘innovation readiness’. Examples of the use of the CAT are presented from South Korea, Thailand, Ireland, Brazil and the UK. [ABSTRACT FROM AUTHOR]

Firms increasingly consider external technology commercialisation (ETC) - the commercialisation of technology assets - as an important part of their strategies. ETC goes beyond the marginal activity of commercialising residual technologies, yet prior research has not systematically analysed its monetary and strategic benefits, nor has much been published about the process of managing ETC. Accordingly this paper offers a classification of ETC objectives based on case studies of 25 technology-oriented companies. A detailed segmentation of the process of managing these projects is established by focussing on large industrial companies whose main business is internal technology exploitation (i.e. the application of technologies in their own products and/or services). Based on these classifications, four types of external technology exploitation projects are identified and the different managerial challenges are described along the process segmentation. [ABSTRACT FROM AUTHOR]

North American, European and Japanese governments have legislated to control Greenhouse Gas emissions and have promoted alternative technology as part of strategies to address climate change. Governments worldwide have sought to encourage adoption of alternative automotive technology by funding demonstrations and in-service trials. Among other initiatives the automotive industry has explored applications of a radical technological innovation - fuel cells - to power a range of vehicles from forklifts to buses. This paper examines the rationale and actions of various stakeholders to facilitate adoption of fuel cell technology in vehicles through a specific market segment - that of fuel cell buses (FCBs) - and explores the progress of FCB projects in North America, Europe and Japan. It examines the role of demonstration projects and highlights the complexity of the relationship between government and developers, and the multifarious and conflicting objectives of industry players that inhibit progress. [ABSTRACT FROM AUTHOR]

This paper evaluates a fellowship scheme aiming to overcome attitudinal and operational barriers towards university technology transfer. We propose barriers exist because of the focus of many academics exclusively within a peer review research network. We explore the case of the Medici Fellowship programme that was implemented in biomedical departments across five universities located in the midlands of England. Our evidence suggests that such fellowship programmes, through the retraining of academics, may have a positive impact on the commercialisation of research. In particular, the fellows, through the enhancement of their social and human capital, are able to act as agents of attitudinal change in their host departments and are seen to build bridges into external business networks that can provide early stage funding, market and legal information and help identify potential customers for nascent academic entrepreneurs. [ABSTRACT FROM AUTHOR]

Emerging technologies present both challenges and opportunities for national technology strategies. National governments may therefore want to monitor the technological horizon on a systematic basis. This article outlines the quantitative approaches available for such monitoring. Among the standard types of bibliometric data, proposals and publications are most likely to be useful for this purpose since they capture information earlier in the cycle of technology development. Patents, in contrast, trail behind. Analysis can proceed with keywords or citations, and algorithms are available to use the information structure inherent in these kinds of data to identify and measure emerging areas. There are limitations, however, in all the available approaches and the authors therefore recommend using them in conjunction with expert methods by focusing the qualitative assessment in particular areas. [ABSTRACT FROM AUTHOR]

Patents can be used by their owners in a variety of strategic ways in the market place that do not necessarily conform with the original idea of patents as a remedy against market failure. More patenting does not lead to more innovation in all cases. This article looks at the relevance of patents and their strategic uses in the biotechnology industry. The article considers the different motives for applying for patents and various strategies. Theoretical considerations are made based on empirical findings from a survey of the Swiss biotechnology industry carried out in 2003. The empirical data confirm that patents for biotechnological inventions are important as an incentive for investment in R&D and that patents are an efficient tool for protecting biotechnological inventions. Strategic patenting is not very common in Switzerland and there are no signs for an abusive level of strategic patenting. [ABSTRACT FROM AUTHOR]